Skip to main content
Equibles

BHST · Bioharvest Sciences Inc.

Track BHST — free

Use BHST with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BHST.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.85 -0.02 (-1.07%) At close · Sep 11
Rebalance outlook locked
Market Cap
$41.94M
Shares
22.67M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.85 Open$1.87 Day$1.80–1.90 52W close$1.80–12.65 Avg vol 30d59K Short int74K · 0.3% float · 2.0d Short vol62% Last earningsAug 11, 2026 DataJan 2021–Sep 2026

Up next

Next earnings call
Oct 17, 2026 Est · unconfirmed · in 5 wks

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+37.0%
Year over year
Operating margin
-16.2%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+30.8%
Year over year · more shares
Price change (1Y)
-74.8%
Trailing year
Short interest
0.3%
Latest settlement · 2.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Bearish Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 15.8 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −53%
below
Price vs 50-day avg −17%
below
RSI (14) 38
neutral
MACD trend Positive
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −11%
trailing
6-month return −57%
trailing
YTD return −64%
this year
Relative strength −75%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $2 › 200d $4 — 200d above 50d
Institutional flow Distributing
-5% holders QoQ · +2 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.33% of float · ▲ +1.3% MoM · 2.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
19 holders — mid 1-yr range
Squeeze score 44
elevated · 0–100
Fundamentals
Fair
Revenue growth +37%
Y/Y
Free cash flow $-9.6M
Quant / Vol
risk profile
Very High
Volatility 77%
annualized · 1-yr
Max drawdown −86%
past year
ATR 8.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Aug 11, 2026
Vinia D2C revenue · full-year 2026 Initiated $33M – $35M
Total revenue · full-year 2026 Initiated $37M – $40M
prior FY $34.51M midpoint +11.6% Y/Y

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−53% Bearish
Price vs 50-day avg
−17% Bearish
RSI (14)
38 Neutral
MACD trend
Positive Bullish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $2 › 200d $4 — 200d above 50d
Institutional flow Distributing
-5% holders QoQ · +2 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.33% of float · ▲ +1.3% MoM · 2.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
19 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $2 Now $2 · 0% Range high $13
vs 200-day avg -53% vs 50-day avg -17%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Packaged Foods — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BHST
Bioharvest Sciences Inc.
this stock
$41.94M -64.4% +37.0% — 0.3%
KHC
Kraft Heinz Co
 $29.17B +1.4% -0.1% — 8.3%
GIS
General Mills Inc
 $19.13B -22.9% +4.1% — 8.6%
MKC
Mccormick & Co Inc
 $13.80B -24.7% +1.7% 8.5 6.0%
JBS
Jbs N.V.
 $13.48B -12.7% — — 3.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
19
% held
7.4%
Net QoQ
-18.3K sh
Top holder
Alyeska Investment Group,…
Held Float
View
Held by Funds
Fund positions
1
View
Short & Settlement
Short Interest Rising
Shares short
73.9K
Days to cover
2.0d
Change
+975 sh
View
Short Volume
Short vol %
62%
As of
Sep 11, 2026
Short Total
View
Fails to Deliver
FTD shares
10.9K
Value
$23.5K
As of
Aug 4, 2026
View
Off-Exchange
Off-exchange %
38.6%
Week of
Aug 3, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$34.5M
Net income (FY)
$-11.1M
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 3, 2026
This year
26
View
Exempt Offerings
Offering
$401.3K
Filed
Oct 6, 2025
View
Earnings & Events
Earnings Calls Upcoming
Next call
Sep 14, 2026
Last call
Aug 12, 2026
View
Investor Relations
Latest news
BioHarvest Sciences Registers for…
Published
Sep 3, 2026
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
BHST +2.8% -10.6% -56.7% -3.1% -64.4%
SPY -1.2% -1.8% +17.8% -0.4% +12.1%
vs SPY +3.9% -8.9% -74.5% -2.8% -76.4%
Key facts CIK 1723464 CUSIP 09076J207 13F (30d) 7 filings 7 filers Visit website Investor relations